← Back to Influence Map
Entity DossierOrganization
TRAVERE THERAPEUTICS
CA · US
Biopharmaceuticals
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$1,956,000
Connections
3
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$3.5MPHAPharmacy
$3.5MMEDMedical/Disease Research
$3.5MMMMMedicare/Medicaid
$3.5MTAXTaxation/Internal Revenue Code
$3.3MCPTCopyright/Patent/Trademark
$2.2MLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$2.2M
ALSTON & BIRD LLP$900K
THE HEALTH EQUITY STRATEGIES GROUP, LLC$248K
2359 STRATEGIES$150K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | ALSTON & BIRD LLP | Hired ALSTON & BIRD LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | 2359 STRATEGIES | Hired 2359 STRATEGIES to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THE HEALTH EQUITY STRATEGIES GROUP, LLC | Hired THE HEALTH EQUITY STRATEGIES GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |